Detalhe da pesquisa
1.
Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease.
Int J Mol Sci
; 24(15)2023 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37569608
2.
Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease.
J Gastroenterol Hepatol
; 37(5): 832-840, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266174
3.
Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD).
Microorganisms
; 9(1)2021 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33477939